Don’t Panic When You Receive a Cancer Report! Understand These 5 Key Sections First
Do you start panicking when you see words such as “mass”, “lesion”, “metastasis”, or “suspicious” in a report?
Key Takeaways
What truly matters is understanding the key sections of the report first, then deciding the next step. This article helps you understand what the report is saying, which information matters most, and what questions to ask your doctor next.
Start with the Big Picture: These Are the 5 Key Sections
Impression / Conclusion / Summary
Start with the summary to understand what the reporting doctor considers the most important findings and overall direction.
Tumor Location, Size, and Extent
Check where the tumor is, how large it is, whether nearby structures are involved, and whether anything has changed.
Lymph Nodes, Metastasis, and Signs of Spread
Review lymph node characteristics, distant lesions, and metabolic activity in PET-CT findings.
Comparison / Previous Report
Compare old and new reports to determine whether the condition appears to be improving, stable, or progressing.
Blood Tests, Tumor Markers, and Organ Function
Do not focus only on the tumor. Review whether the body can tolerate treatment by examining blood counts, liver and kidney function, inflammation, nutrition, and tumor-marker trends.
Section 1: Start with Impression / Conclusion / Summary
In many CT, PET-CT, MRI, and some pathology reports, the key points may be summarized under Impression, Conclusion, or Summary.
A Short Conclusion Does Not Mean a Simple Situation
The Findings section may contain subtle changes that require clinical judgment to determine their importance.
“Suspicious” Is Not the Same as a Final Diagnosis
For example, “suspicious for metastasis” should be interpreted by reviewing the lesion's location, appearance, size, and supporting evidence.
Section 2: Look at the Tumor Location, Size, and Extent
A cancer report is not only about whether cancer is present. You also need to look at:
Why Does This Information Matter?
Section 3: Check for Lymph Nodes, Metastasis, or Signs of Spread
One of the biggest concerns for families is: Has it spread?
“Lymph Nodes Seen”
This may simply describe visible lymph nodes and does not automatically indicate abnormality.
“Mild Enlargement”
This deserves attention, but enlargement may also occur with inflammation or infection.
Abnormal Morphology
Irregular margins or abnormal internal structure may deserve further assessment.
Multiple Enlarged Nodes
Distribution, cancer type, history, and other investigations need to be considered together.
Common Sites Mentioned in Reports
PET-CT: Pay Special Attention to SUV
SUV, or Standardized Uptake Value, reflects the degree of radiotracer uptake and may be used as a reference for metabolic activity.
Section 4: Look at Comparison / Previous Report
This section is extremely important because many people focus on a single report and overlook the trend.
A 2 cm Tumor
Without an older report, you may not know whether it has been stable for a long time or appeared recently.
An Enlarged Lymph Node
Without comparison, you may not know whether it has always been that size or recently enlarged.
Practical Advice for Families
Section 5: Check Blood Tests, Tumor Markers, and Organ Function
Cancer treatment is not only about the tumor. It is also about whether the body can tolerate treatment. Blood tests help assess the current physical state, treatment tolerance, and which issues may need priority attention.
Complete Blood Count (CBC)
WBC: helps assess white blood-cell status and infection-related risk.
RBC / Hemoglobin: helps assess anemia.
Platelets: helps assess platelet status and bleeding-related concerns.
Liver Function
ALT, AST, ALP, GGT, and Bilirubin abnormalities may relate to medications, liver disease, biliary problems, or other causes and need to be interpreted with trends and imaging.
Kidney Function
Creatinine, eGFR, and Urea help assess renal filtration and metabolic status. In general, rising creatinine or urea, or a falling eGFR, may require assessment together with age, hydration, medications, and the broader clinical picture.
Inflammation and Nutrition
CRP / ESR: reflect inflammation-related changes but are not cancer-specific.
Albumin / Total Protein: may support assessment of nutritional and overall physical status.
Common Tumor Markers
Tumor markers may support assessment and treatment monitoring, but they usually cannot diagnose cancer on their own. Trends, imaging, pathology, and the broader clinical picture matter.
The Role of Pathology Reports and Genetic Testing
Pathology Reports May Help Confirm
Cancer type, histologic features, Grade, Margin status, lymph-node involvement, and important information relevant to staging. Final stage commonly integrates pathology, imaging, surgical findings, and clinical information.
Genetic Testing May Indicate
Specific mutations, biomarkers relevant to certain targeted or immunotherapy options, and possible hereditary risk.
After Understanding These 5 Sections, What Should You Do Next?
Understanding a report is not the endpoint. It is the starting point. Report analysis should help you know what to ask, what to do, and what to watch next.
Important Reminder: Understanding Reports Is Not About Becoming Your Own Doctor
How BezLife Helps Turn Reports into Directions Patients and Families Can Understand and Act On
BezLife's Medical Report Analysis is not only about explaining what is written in a report. It helps patients and families organize key concerns, risk priorities, and possible next directions for health management.
Confused by a Cancer Report? Start by Organizing the Key Questions
Contact the Dr Victor Team. Through report organization and one-to-one consultation, we help patients and families understand the current situation, identify priority concerns, and prepare clearer questions for discussion with their medical team.

